Source author record

Samantha Liang

Samantha Liang appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

1works
2topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2026arXiv

FRESH: Information-Geometric Calibration of Patient-Level Models to Aggregate Evidence

This note introduces FRESH (Fusion of Recent Evidence and Subject Histories), a method for incorporating population-level summary results -- published clinical trials, registry summaries, prior natural-history studies, and peer-reviewed indirect comparisons -- into predictive models trained on patient-level data. This method provides a principled means of combining both patient-level and aggregate-level data types into a unified data-efficient model for clinical decision making. FRESH assumes access to a generative model trained on patient-level data sources (e.g. clinical trial or real-world data). The method produces patient-level predictions from a re-calibrated model that matches a set of specified aggregate statistics for a target population. This can be understood as a patient-level recapitulation of the aggregate source -- with the key property that the recalibration is a minimal perturbation of the original joint distribution in a specific information-geometric sense. The resulting samples can be analyzed directly or combined into a post-training procedure to update the original generative model. This approach enables several applications where rigorously incorporating patient-level data with summary information is valuable, including (i) contextualizing single-arm trial results with respect to recent standard-of-care, (ii) clinical-trial simulations for design and probability-of-technical-success estimation, and (iii) comparative-effectiveness analyses of on-market therapies.